Reblozyl® (luspatercept‐aamt) is Now Approved

This site is intended for U.S. audiences only.

Sign Up for Information
Full Prescribing Information
Healthcare Professional Site

Key Resources

Celgene Patient Support^®

A Specialist is available to help patients with:

Understanding their health insurance coverage for REBLOZYL
Learning about financial assistance that may help eligible patients pay for REBLOZYL
Obtaining information about organizations that may assist with travel costs to and from the doctor’s office

Learn More

Download the full Prescribing Information

Download

REBLOZYL patient brochure

Coming Soon

Register to receive more information about REBLOZYL

*Required field
First Name**
Last Name**
Email**
ZIP Code**
Phone Number*

Celgene values your privacy. Celgene, its affiliates, and its agents will not sell or rent your personal information.
By providing your information, you acknowledge that you have read and agree to the terms of Celgene's Privacy Policy.

Let us know what kind of content you're looking for
What topics are you interested in learning more about? (check all that apply)
- Information about disease state
- General patient support
- Support groups
- Financial information
- Doctor/patient conversations
- Caregiver support
- Symptom monitoring
In which formats would you like to receive information? (check all that apply)
- A welcome kit
- Email updates
- SMS updates
- Direct mail
- Downloadable brochures
- Videos
- A mobile application
- Social media

TO REPORT SUSPECTED ADVERSE REACTIONS OR EMBRYO-FETAL EXPOSURE: CONTACT CELGENE CORPORATION AT 1‑888‑423‑5436 OR FDA AT 1‑800‑FDA‑1088 OR WWW.FDA.GOV/MEDWATCH.

Full Prescribing Information
Contact Us
Privacy Policy
Terms of Use

This site is intended for U.S. audiences only.

REBLOZYL^® and Celgene Patient Support^® are registered trademarks of Celgene Corporation.

REBLOZYL^® is licensed from Acceleron Pharma Inc.

Please choose an option:

Enter Patient Site Visit Healthcare Professional Site

The information contained in this website is intended for U.S. audiences only.

You are now leaving the REBLOZYL.com website.

Do you wish to leave this site?

Yes No

BMS Logo

BMS is committed to providing continued access to medicines for the patients who depend on us. For any questions about BMS medicines during this time, please contact 1-800-721-8909.

Key Resources

Celgene Patient Support®

Download the full Prescribing Information

REBLOZYL patient brochure

Register to receive more information about REBLOZYL

Let us know what kind of content you're looking for

Please choose an option:

Celgene Patient Support^®